Birmingham, West Midlands -- (SBWIRE) -- 10/23/2013 -- Value Penny Stocks issues special report on Allied Nevada Gold Corp. (NYSEMKT:ANV), Lattice Semiconductor (NASDAQ:LSCC), ARMOUR Residential REIT, Inc. (NYSE:ARR), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA).
Allied Nevada Gold Corp. (NYSEMKT:ANV) opened its last trade at the price of $4.23. Its closing price was $4.34 after gaining 5.85% for the day. The company traded with the total volume of 4.66 million shares, while its average trading volume remained 5.65 million shares. The beta of this stock stands at 1.38. Allied Nevada Gold Corp., a gold and silver producer, focuses on the mining, development, and exploration of properties in Nevada. The company’s principal products include unrefined gold and silver bars.
For How Long ANV will Fight for Profitability? Read This Trend Analysis report
Lattice Semiconductor (NASDAQ:LSCC) percentage change plunged -1.01% to close at $4.41 with the total traded volume of 1.14 million shares, along with average volume of 943,995.00 shares. The 52 week range of the stock remained $3.54 - $5.70, while its day lowest price was $4.39. The share price hit the day highest price of $4.55. Lattice Semiconductor Corporation designs, develops, and markets programmable logic products and related software in Asia, Europe, and the Americas.
Has LSCC Found The Bottom And Ready To Gain Momentum? Find Out Here
ARMOUR Residential REIT, Inc. (NYSE:ARR) traded on volume of 3.27 million shares in the last session against average volume of 5.20 million shares. The company started its trading session with the price of $4.37 and closed at $4.42 by scoring +1.84%. ARMOUR Residential REIT, Inc.( ARMOUR) is an externally-managed Maryland corporation managed by ARMOUR Residential REIT, Inc. The Company invests primarily in hybrid adjustable rate, adjustable rate and fixed rate residential mortgage backed securities (RMBS).
Will ARR Continue To Move Higher? Find Out Here
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) started its last trading session with the price of $4.39 and closed at $4.44 by scoring +1.14%. The stock traded with total volume of 2.76 million shares, while the average trading volume remained 2.76 million shares. The beta value of this stock stands at 0.05. Day range for the stock was $4.35 - $4.47. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)